Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons

Abstract

There was substantially less Alzheimer disease (AD) neuropathology in the medicated hypertension group than the nonhypertensive group, which may reflect a salutary effect of antihypertensive medication against AD-associated neuropathology.